28.8 C
Vientiane
Friday, July 11, 2025
spot_img
Home Blog Page 428

Lao New Year Wrap: Tradition, Festivities, International Engagement

Sang Khan Procession in Luang Prabang
Sang Khan Procession in Luang Prabang. (Mimi Oulayvanh Sisounonth)

From 14 to 16 April, Laos burst into a celebration as the country officially marked Pi Mai Laos—the Lao New Year. From alms-giving ceremonies and traditional processions to water splashing battles, the nation came together to usher in the new year.

Tomorrowland Brasil 2025 General Sale in Full Swing — Exclusive Cashback for Bybit Cardholders

DUBAI, UAE, April 18, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, highlights that general ticket sales for Tomorrowland Brasil 2025 are currently ongoing, with exclusive benefit available to Bybit Card and Bybit Pay eligible users such as 20% cashback.

The Bybit Card is designed for global use and supports both fiat currencies—ARS, BRL, EUR, USD—and a wide selection of cryptocurrencies. Integrated with Apple Pay, Google Pay, and Samsung Pay, it offers users up to 10% cashback on everyday purchases, 8% APR through Auto-Savings, free worldwide delivery, and $100 in monthly ATM withdrawals at no cost—without any annual fees.

Returning to the vibrant setting of Parque Maeda in Itu, São Paulo, Tomorrowland Brasil 2025 will take place from October 12 to 14, promising three days of music, imagination, and cultural exchange. Famed for its theatrical stages, global audience, and meticulously curated lineup, Tomorrowland is more than a festival—it’s a world of its own. With each edition, it transforms into a breathtaking playground of light, sound, and storytelling, drawing music lovers from over 100 countries to celebrate unity through electronic music.

This year’s Brazilian edition will feature performances from some of the world’s most sought-after artists, including David Guetta, Armin van Buuren, Vintage Culture, Mind Against, Steve Aoki, James Hype, Alesso, Nervo, and I Hate Models. Special acts include Alok’s “Something Else” concept, ANNA b2b Vintage Culture, and a powerful b2b set from Matisse & Sadko and Third Party. With more names still to be revealed, the event is shaping up to be one of the strongest editions yet.

“Tomorrowland Brasil is one of those rare experiences that transcends music—it creates lasting memories and connects people from every walk of life,” said Joan Han, Head of Payment business unit at Bybit. “We’re proud to support this global celebration by offering our users exclusive benefits that make it easier to be part of something truly unforgettable.”

Tomorrowland Brasil continues to be a beacon of creativity, community, and connection, standing at the intersection of music, technology, and art.

Tomorrowland Brasil 2025 General Sale in Full Swing — Exclusive Cashback for Bybit Cardholders
Tomorrowland Brasil 2025 General Sale in Full Swing — Exclusive Cashback for Bybit Cardholders

#Bybit / #TheCryptoArk

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 60 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

About TOMORROWLAND BRASIL

Tomorrowland Brasil 2025 will take place on October 10-12 in the beautiful festival area of Parque Maeda in Itu, a municipality in São Paulo. The festival will revolve around the mesmerizing ‘LIFE’ theme, set against the backdrop of Brazil’s enchanting natural beauty. A story set in the mythical realm of Silvyra, it’s a world unto its own, filled with creatures, plant life, and people living in harmony, each with their own stories, with the diversity of Silvyra’s lush nature represented in the spectacular ‘LIFE’ Mainstage. Offering the ultimate escape from the city during three days of bliss, guests will be treated to breathtaking performances by more than 150 of the world’s finest electronic artists across 6 mesmerizing stages.

The first two festival editions of Tomorrowland Brasil took place in 2015 and 2016 in the beautiful festival area of Parque Maeda in Itu, São Paulo. After years of dreaming of a return, Tomorrowland finally headed back to Brazil in 2023, becoming a yearly highlight once again.

Tomorrowland Brasil 2025
October 10-12, 2025
Parque Maeda, Itu
brasil.tomorrowland.com

LightInTheBox Announces Strategic Initiatives to Leverage and Enhance Its Manufacturing Capabilities and D2C Model

SINGAPORE, April 18, 2025 /PRNewswire/ — LightInTheBox Holding Co., Ltd. (NYSE: LITB) (“LightInTheBox” or the “Company”), a global online retail company, today announced strategic initiatives aimed at leveraging and enhancing its manufacturing capabilities and Direct-to-Consumer (D2C) model. Through these initiatives, the Company seeks to maintain competitive pricing and ensure customer satisfaction in key markets.

Strategic Manufacturing Enhancements

Building on years of experience and customer insights, LightInTheBox has developed its in-house manufacturing capabilities over the past year. A significant portion of its products is now produced internally, facilitating a transition to a Manufacturer-to-Consumer (M2C) model. This approach minimizes intermediary costs, enabling the Company to better reduce expenses more effectively than traditional retailers.

Agile Inventory Management

Adopting a “light inventory” strategy, LightInTheBox has shifted from bulk stocking to small-batch production. This “small-batch, quick-response” model enhances the Company’s ability to adapt to market fluctuations, minimize overstock risks, and respond promptly to consumer demands.

Strengthening D2C Brand Portfolio

The Company continues to build a robust D2C brand matrix, emphasizing “designed in California” to reinforce its American brand identity. By highlighting U.S.-based design elements, LightInTheBox aims to align more closely with local consumer preferences and bolster brand loyalty.

Enhancing Brand Value and Customer Engagement

LightInTheBox is committed to delivering exceptional brand value by cultivating private traffic channels, including email marketing and social media communities. This strategy reduces reliance on third-party platforms and price-sensitive consumers, fostering a more engaged and loyal customer base.

About LightInTheBox Holding Co., Ltd.

LightInTheBox is a global specialty retail company, providing a diverse range of affordable lifestyle products directly to consumers worldwide since 2007. In 2024, the Company shifted its focus to apparel design and launched its first proprietary brand, Ador.com, to meet the growing global demand for accessible higher-end fashion. Ador.com specializes in designer-quality clothing for women aged 35-55 at competitive prices and operates design studios and sample shops in both the U.S. and China, including a boutique and design studio in Campbell, California. Additionally, LightInTheBox offers a comprehensive suite of services to e-commerce companies, including advertising, supply chain management, payment processing, order fulfillment, and shipping and delivery solutions. For more information, please visit https://ir.ador.com

Safe Harbor Statement

This press release contains forward-looking statements that involve risks and uncertainties. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “potential,” “continue,” “ongoing,” “targets” and similar statements. Among other things, statements that are not historical facts, including statements about LightInTheBox’s beliefs and expectations, the business outlook and quotations from management in this announcement, as well as LightInTheBox’s strategic and operational plans, are or contain forward-looking statements. LightInTheBox may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: LightInTheBox’s goals and strategies; LightInTheBox’s future business development, results of operations and financial condition; the expected growth of the global online retail market; LightInTheBox’s ability to attract customers and further enhance customer experience and product offerings; LightInTheBox’s ability to strengthen its supply chain efficiency and optimize its logistics network; LightInTheBox’s expectations regarding demand for and market acceptance of its products; competition; fluctuations in general economic and business conditions and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in LightInTheBox’s filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and LightInTheBox does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Investor Relations Contact

Investor Relations
LightInTheBox Holding Co., Ltd.
Email: ir@ador.com

Jenny Cai
Piacente Financial Communications
Email: ador@tpg-ir.com

Brandi Piacente
Piacente Financial Communications
Tel: +1-212-481-2050
Email: ador@tpg-ir.com

 

Watch Green, Live Green: Yaber T2 Outdoor Edition is Your Earth Day Must-Have

NEW YORK, April 18, 2025 /PRNewswire/ — As Earth Day 2025 approaches, Yaber (www.yaber.com) invites outdoor enthusiasts and eco-minded explorers to celebrate in style with the T2 Outdoor Edition — a portable projector crafted for adventure, sustainability, and fun under the stars. Engineered for those who cherish both nature and entertainment, the T2 Outdoor Edition brings immersive viewing experiences to the great outdoors without leaving a footprint.

Yaber T2 Outdoor Edition
Yaber T2 Outdoor Edition

Ditch the outlets, Embrace the outdoors

Inspired by nature, the T2 Outdoor Edition features a camouflage color palette in rock gray and dune brown, blending effortlessly into natural landscapes. Whether you’re deep in the wilderness or relaxing in your backyard, its lightweight design and built-in battery eliminate the need for outlets, giving you true freedom to stream movies, music, or live sports wherever your path leads.

Inspired by nature, made for nature

The T2 Outdoor Edition features a nature-ready design in rock gray and dune brown, camouflaging beautifully with forest floors, mountain trails, or desert sands. Its durable yet stylish casing reflects a love for the outdoors, while its eco-conscious engineering minimizes power consumption.

Celebrate Earth Day, the Yaber way

To inspire more people to enjoy low-impact, high-fun outdoor experiences, Yaber is launching a special ‘Save the Planet with Yaber’ giveaway on Instagram on April 22, 2025. Followers will have the chance to win their own T2 Outdoor Edition and get inspired to bring their entertainment into the wild. Be sure to follow Yaber on Instagram, Facebook, and TikTok to join the celebration, discover outdoor inspiration, and enter the giveaway.

And for those ready to bring the adventure home, Yaber’s Amazon stores in the US, UK, France, and Germany will feature a Earth Day promotion on the T2 Outdoor Edition. Enjoy special pricing during this celebration:

Don’t miss this chance to gear up for outdoor adventures with an eco-friendly projector at a great value. Search ‘Yaber’ on Amazon to explore more!

Akeso’s Ebdarokimab ( IL – 12/IL – 23 Dual – Targeted Monoclonal Antibody) Approved in China for Moderate – to – Severe Plaque Psoriasis

HONG KONG, April 18, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) is pleased to announce that ebdarokimab, an investigational monoclonal antibody developed by the company, has received marketing approval from the National Medical Products Administration (NMPA) for the treatment of moderate-to-severe plaque psoriasis in adult patients.

Ebdarokimab is the company’s first Class 1 new drug approved for autoimmune diseases and the second non-oncology new drug to receive marketing approval, following ebronucimab (PCSK9). This approval expands Akeso’s commercial portfolio outside of oncology.

Ebdarokimab was evaluated in five clinical studies involving Chinese patients with moderate-to-severe plaque psoriasis. Two pivotal Phase III studies demonstrated ebdarokimab’s efficacy and safety at both 16 weeks and 52 weeks in these patients.

Positive Short-Term Efficacy: Patients receiving ebdarokimab injection 135mg with two doses at weeks 0 and 4 showed a significantly positive efficacy, with a PASI 75 response rate of 79.4% at week 16.

Sustained Long-Term Efficacy: Patients receiving ebdarokimab injection 135mg every 12 weeks (Q12W) for maintenance therapy achieved long-term durable efficacy, with a PASI 75 response rate of 77.9% at week 52.

Significant Improvement in Quality of Life: Long-term maintenance treatment with ebdarokimab significantly improved patients’ quality of life, alongside the improvement of skin lesions. After 16 weeks of treatment, the impact of skin disease on patients’ quality of life decreased by more than 55%, further decreasing to over 65% by week 52.

Good Safety Profile: The incidence of adverse events was low and numerically lower than that of the placebo group.

Convenience of Administration: Ebdarokimab, administered as four subcutaneous injections annually, provides treatment convenience and provides long-term, stable improvements in treatment efficacy and patients’ quality of life.

The clinical data for ebdarokimab was previously reported at the European Academy of Dermatology and Venereology (EADV) congress in 2023 and 2024.

Professor Jianzhong Zhang, lead investigator of the pivotal trials and Director of Peking University People’s Hospital Dermatology Department, commented: “Clinical data consistently demonstrate ebdarokimab’s rapid onset, durable efficacy, and excellent safety profile. With only four doses per year, it offers enhanced treatment adherence, enabling long-term disease control and improved quality of life. As clinicians, we believe ebdarokimab will provide a more accessible, effective, and convenient therapeutic option for patients.”

Dr. Yu Xia, Founder, Chairwoman, President and CEO of Akeso, stated: “In addition to our oncology focus, Akeso has built a forward-looking, innovative pipeline targeting high-prevalence, high-potential disease areas, including metabolic, autoimmune, inflammatory, and neurodegenerative diseases. Our products are steadily entering the commercialization phase. With the successful launches of ebronucimab and ebdarokimab, along with the late-stage clinical development of competitive pipelines like gumokimab (IL-17 monoclonal antibody) and mandokimab (IL-4R monoclonal antibody), as well as the progress of new mechanism drugs, such as the first IL-4R/ST2 bispecific antibody in autoimmune diseases and therapies for neurodegenerative conditions, Akeso’s global portfolio and competitive edge in non-oncology fields are strengthening. We eagerly anticipate the early approval of more of Akeso’s independently developed non-oncology drugs, offering improved treatment outcomes for patients worldwide.”

About Ebdarokimab (IL – 12/IL – 23 Monoclonal Antibody)

Ebdarokimab is a novel humanized monoclonal antibody targeting IL-12/IL-23, developed by Akeso. Ebdarokimab is indicated for the treatment of psoriasis, ulcerative colitis, and other autoimmune disorders. By inhibiting the biological activity of cytokines IL-12 and IL-23, it provides therapeutic benefits in autoimmune diseases. Psoriasis pathogenesis is associated with dysregulated immune responses, where IL-12 and IL-23, cytokines sharing a common p40 subunit, play pivotal roles in inflammation and immune modulation. IL-12 induces the activation and proliferation of Th1 cells (T helper cells 1), which secrete interferon-γ and TNF-α (tumor necrosis factor α), while IL-23 is involved in the differentiation of Th17 cells (T helper cells 17), leading to the release of IL-17 (interleukin-17). These cytokines are key mediators in inflammatory processes. Ebdarokimab binds to the p40 subunit of IL-12 and IL-23, preventing their interaction with cell surface receptors, thereby attenuating the release of cytokines such as interferon-γ, TNF-α, and IL-17 from T cells. This inhibition of cytokine-driven immune responses effectively modulates the aberrant immune activity in psoriasis.

About Akeso Inc.

Akeso,Inc. is a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of innovative antibody drugs that are affordable to patients worldwide. Since the Company’s inception, the Company has established an end-to-end comprehensive drug development platform (ACE Platform), encompassing fully integrated drug discovery and development functions, including target validation, antibody drug discovery and development, CMC production process development, and GMP compliant production. The Company has also successfully developed a bi-specific antibody drug development technology (Tetrabody technology) that can overcome three CMC challenges in the development and manufacturing of bi-specific antibodies: 1.low expression levels, 2. process development hurdles, and 3. antibody stability and druggability.

The Company currently has a portfolio of over 50 innovative programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. Among these programs are 6 approved products independently developed by the Company and 2 products under NDA review by the NMPA. We are conducting Phase III clinical trials of 12 products, and Phase I/II clinical trials of other 12 products. 15 of the products are potential global first-in-class (FIC) or best-in-class (BIC) bi-specific antibodies/polyclonal antibodies/bi-specific ADCs. The Company’s vision is to become a leading global biopharmaceutical company through focused innovation in R&D, the establishment of world class manufacturing, and continued expansion commercial network.

Heaven747 Songkran Festival 2025 Marks the Start of a New Era for New Poipet, Cambodia

POIPET, Cambodia, April 18, 2025 /PRNewswire/ — The highly anticipated Heaven747 Songkran Festival 2025 made history with the world’s first Songkran Festival held aboard a Boeing 747 aircraft. Over 20,000 attendees celebrated across three unforgettable days, from April 13–15, 2025, solidifying Heaven747 as a symbol of New Poipet’s new entertainment future.

Heaven747 Songkran Festival 2025 Marks the Start of a New Era for New Poipet, Cambodia
Heaven747 Songkran Festival 2025 Marks the Start of a New Era for New Poipet, Cambodia

The festival featured a powerful lineup of top international DJs, including BOTCASH, DUBVISION, VINAI, RAYRAY, BEAUZ, WUKONG, and more, transforming New Poipet into a true global music destination. The event seamlessly blended traditional Thai New Year celebrations with the energy of a world-class EDM Music Festival, featuring 360° water zones, drone shows, fireworks, and immersive light displays.

Heaven747 Songkran Festival 2025 Marks the Start of a New Era for New Poipet, Cambodia
Heaven747 Songkran Festival 2025 Marks the Start of a New Era for New Poipet, Cambodia

 

Heaven747 Songkran Festival 2025 Marks the Start of a New Era for New Poipet, Cambodia
Heaven747 Songkran Festival 2025 Marks the Start of a New Era for New Poipet, Cambodia

The success of Heaven747 marks the beginning of a bold new vision for New Poipet — a city set to transform into a mega project of modern lifestyle, entertainment, and innovation. New Poipet aims to redefine itself as the next major hub for festivals, nightlife, and dynamic urban experiences in Cambodia.

This landmark event proves that New Poipet, Cambodia, is ready to step onto the global stage. And this is just the beginning.

Let’s see what’s happening next.

More Information: heaven747.com
Join the community: Telegram – Heaven747

Squirrel Ai Co-Founder Joleen Liang Highlights the Role of AI in Critical Thinking at ASU+GSV Summit

SHANGHAI, April 18, 2025 /PRNewswire/ — The ASU+GSV Summit, co-hosted by Arizona State University (ASU) and Global Silicon Valley (GSV), recently kicked off at the Manchester Grand Hyatt in San Diego, California. Themed ‘Learning at the Speed of Light’, the event drew over 7,000 educators, business owners, investors, and policymakers, including Khan Academy founder Sal Khan and Stanford University’s Prof. Andrew Ng (co-founder of Coursera).

Among the distinguished speakers was Dr. Joleen Liang, co-founder of Squirrel Ai Learning, who joined a high-profile panel with Khan Academy Chief Learning Officer Kristen DiCerbo and SchoolAI CEO Caleb Hicks to explore “Cultivating Critical Thinking in the Age of AI Tutors”. 

Hailed as the ‘Davos of EdTech’, the ASU+GSV Summit is one of the most influential events in global education and workforce learning. It provides a platform for leading innovators across the “PreK to Gray” (early childhood through lifelong learning) sector to exchange ideas, share best practices, and explore opportunities for collaboration.

Dr. Liang opened the discussion with a compelling thesis: “AI won’t replace human thought—it’s a tool to ignite deeper cognition”. She elaborated on this viewpoint by citing the company’s proprietary large adaptive model (LAM) for multimodal education as an example.

With the growing popularity of general-purpose AI led by LLMs and ChatGPT, Squirrel Ai Learning ‘s multimodal LAM remains laser-focused on the education sector. Leveraging 117 patented technologies, including fine-grained knowledge component decomposition and root-cause analysis, it dynamically tracks students’ problem-solving processes to deliver truly personalized learning solutions. This ensures every learner discovers their optimal study method, accelerating the progress of adaptive education.

Squirrel Ai’s all-subject multimodal adaptive learning model enhances intelligent human-computer interaction, enabling seamless voice and text-based engagement with students. For instance, when a student solves a math problem, instead of just grading the answer, Squirrel Ai Learning’s adaptive tutoring system guides them with Socratic questioning: “Would the conclusion hold if the conditions change?” This approach encourages students to think independently and deepen their understanding by prompting them to verify their logic and re-evaluate problem-solving strategies.

Squirrel Ai Learning’s MCM (Model of thinking, Capacity, Method) model further helps students uncover latent strengths. Dr. Liang emphasized, “We’re nurturing adaptable thinkers—not training machine-dependent learners—and we believe it will benefit them for life.”


Squirrel Ai Learning’s innovations earned it a spot on the 2025 GSV 150 list, which evaluates over 2, 500 global companies backed by venture capital and private equity, and won the Most Transformational Growth Companies In Digital Learning and Workforce Skills award.

During the summit, many international educators recognized and praised Squirrel Ai Learning ‘s LAM model. Michael Horn from the Harvard Graduate School of Education shared that he frequently cites the company’s adaptive tutoring system as a case study in his courses, commending its decade-long technological evolution and continued innovation.

According to publicly available data, the company allocates 30% of its annual revenue to R&D as part of its mission to make quality education more accessible. It has built a top-tier research team that brings together leading AI scientists and education professionals from around the globe, while collaborating with leading universities and research organizations worldwide. To date, Squirrel Ai Learning has opened over 3,000 physical learning centers across China and partnered with more than 60,000 public schools, collecting  nearly 10 billion learning behavior data points from over 24 million students.

As the deep integration of AI and education emerges as a central theme in education reform, Squirrel Ai Learning ‘s adaptive learning system offers the industry a tangible solution: AI should never replace student thinking but rather serve as a cognitive partner that cultivates critical thinking. The future of high-quality education requires both relentless innovation in technology and the commitment to preserve the human element that nurtures original thought.

Contact:
Li Huang
huangli@songshuai.com

So-Young International Inc. Files Its Annual Report on Form 20-F

BEIJING, April 18, 2025 /PRNewswire/ — So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission on April 18, 2024. The annual report is available on the Company’s investor relations website at https://ir.soyoung.com/.

The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be submitted to ir@soyoung.com.

About So-Young International Inc.

So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”) is the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments. The Company provides access to aesthetic treatments through its online platform and branded aesthetic centers, offering curated treatment information, facilitating online reservations, delivering high-quality treatments, and developing, producing and distributing optoelectronic medical equipment and injectable products. With its strong brand recognition, digital reach, affordable treatments and efficient supply chain, So-Young is well-positioned to serve its audience over the long term and grow along the medical aesthetic value chain.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Among other things, the Financial Guidance and quotations from management in this announcement, as well as So-Young’s strategic and operational plans, contain forward-looking statements. So-Young may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including but not limited to statements about So-Young’s beliefs and expectations, are forward-looking statements. Forward looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: So-Young’s strategies; So-Young’s future business development, financial condition and results of operations; So-Young’s ability to retain and increase the number of users and medical service providers, and expand its service offerings; competition in the online medical aesthetic service industry; changes in So-Young’s revenues, costs or expenditures; Chinese governmental policies and regulations relating to the online medical aesthetic service industry, general economic and business conditions globally and in China; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in the Company’s filings with the Securities and Exchange Commission. All information provided in this press release and in the attachments is as of the date of the press release, and So-Young undertakes no duty to update such information, except as required under applicable law.

For more information, please contact:
So-Young

Investor Relations
Ms. Mona Qiao
Phone: +86-10-8790-2012
E-mail: ir@soyoung.com

Christensen

In China
Ms. Dee Wang
Phone: +86-10-5900-1548
E-mail: dee.wang@christensencomms.com

In US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
Email: linda.bergkamp@christensencomms.com